Ozempic, Wegovy & Zepbound: What's the Difference Between These GLP-1 Medications?
Ozempic. Wegovy. Zepbound.
These three names have become almost impossible to avoid in conversations about GLP-1 medications and weight loss. They're mentioned in news stories, social media posts, doctor's offices, and countless before-and-after stories.
But are they actually the same thing?
No.
Ozempic and Wegovy both contain semaglutide. Zepbound contains a different active ingredient called tirzepatide. And while Wegovy and Zepbound are FDA-approved for chronic weight management in eligible patients, Ozempic's FDA-approved indications center on type 2 diabetes and associated health risks—not weight loss itself.
Understanding those differences can make the rapidly changing world of GLP-1 medications much easier to navigate.
Here's a plain-English explanation of Ozempic vs. Wegovy vs. Zepbound—and why knowing the name of your medication is only the beginning of understanding your own GLP-1 journey.
Ozempic vs. Wegovy vs. Zepbound: The Quick Explanation
Before getting into the details, here's the easiest way to remember the three medications.
Ozempic contains semaglutide. It is a GLP-1 receptor agonist and is primarily associated with the treatment of type 2 diabetes. It is not FDA-approved specifically for weight loss.
Wegovy also contains semaglutide. It is a GLP-1 receptor agonist and is FDA-approved for chronic weight management in eligible patients, along with other approved indications.
Zepbound contains tirzepatide. Unlike semaglutide, tirzepatide activates two hormone receptors—GIP and GLP-1. Zepbound is FDA-approved for chronic weight management in eligible adults, among other approved uses.
So while these three medications are often grouped together, they aren't interchangeable.
What Is Ozempic?
Ozempic is a brand-name medication containing semaglutide.
Semaglutide is a GLP-1 receptor agonist, meaning it activates receptors for glucagon-like peptide-1, a hormone involved in processes including blood glucose regulation, digestion, appetite, and food intake.
Ozempic is FDA-approved for adults with type 2 diabetes for purposes that include improving blood glucose control alongside diet and exercise. Its approved indications also include reducing certain cardiovascular risks and, under current labeling, reducing the risk of worsening kidney disease and related outcomes in certain adults with type 2 diabetes and chronic kidney disease.
Here's the distinction that's particularly important for anyone researching Ozempic weight loss:
Ozempic is not FDA-approved specifically for weight loss.
Weight loss can occur in people taking Ozempic, but that does not make weight management its FDA-approved indication.
That distinction frequently gets lost online because people sometimes use "Ozempic" as though it were a generic term for all GLP-1 weight-loss medications.
It isn't.
Ozempic is one specific semaglutide product with its own approved uses.
What Is Wegovy?
Wegovy also contains semaglutide.
Yes—the same active ingredient found in Ozempic.
But Wegovy is a different FDA-approved product with different indications, formulations, doses, and prescribing instructions.
Wegovy is FDA-approved, along with diet and physical activity, to reduce excess body weight and maintain weight reduction long term in eligible patients.
It also has other FDA-approved indications, including reducing the risk of certain major cardiovascular events in eligible adults with cardiovascular disease and obesity or overweight.
There's another important distinction to understand:
Wegovy and Ozempic aren't the same medication simply because they contain the same active ingredient.
Different branded products containing the same ingredient can have different FDA-approved uses, strengths, dosing schedules, formulations, and prescribing instructions.
That's why you shouldn't assume that information about one semaglutide product automatically applies to another.
If Ozempic and Wegovy Both Contain Semaglutide, Why Aren't They the Same?
This is probably one of the biggest sources of confusion surrounding these medications.
Both contain: semaglutide.
But the product itself matters.
A simple way to remember the distinction is:
Ozempic → semaglutide product primarily associated with type 2 diabetes treatment
Wegovy → semaglutide product approved for chronic weight management in eligible patients
That's a simplified explanation because both products have additional approved indications, but it captures the key difference for someone trying to understand Ozempic vs. Wegovy.
Think about the active ingredient and the branded medication as two different pieces of information.
Knowing the active ingredient tells you what drug you're dealing with.
Knowing the specific product tells you much more about how and why that drug has been approved for use.
What Is Zepbound?
Now we move away from semaglutide.
Zepbound contains tirzepatide.
Tirzepatide differs from semaglutide because it activates two hormone receptors rather than one.
Those receptors are GLP-1 and GIP.
GIP stands for glucose-dependent insulinotropic polypeptide.
Because tirzepatide acts on both pathways, it is generally described as a dual GIP/GLP-1 receptor agonist.
Zepbound is FDA-approved, together with reduced-calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in eligible adults.
It also has an FDA-approved indication for treating moderate-to-severe obstructive sleep apnea in adults with obesity.
So although Zepbound is frequently discussed alongside Wegovy and Ozempic, it contains an entirely different active ingredient.
Is Zepbound the Same as Mounjaro?
No—but the relationship may sound familiar.
Zepbound and Mounjaro both contain tirzepatide.
That's similar to the relationship between Wegovy and Ozempic.
Here's an easy way to remember the four brand names:
Semaglutide is the active ingredient in Ozempic and Wegovy.
Tirzepatide is the active ingredient in Mounjaro and Zepbound.
Mounjaro has an FDA-approved indication for improving blood glucose control in people with type 2 diabetes, while Zepbound has FDA-approved weight-management indications.
Once again, the active ingredient may be the same, but that doesn't mean the branded medications should automatically be treated as interchangeable.
Semaglutide vs. Tirzepatide: The Bigger Difference
Once you understand the brand names, the comparison becomes much easier.
Ozempic and Wegovy belong on the semaglutide side.
Zepbound belongs on the tirzepatide side.
And the medications work somewhat differently.
Semaglutide
Semaglutide is a GLP-1 receptor agonist.
It activates GLP-1 receptors and can influence appetite and food intake as well as other metabolic processes.
Tirzepatide
Tirzepatide activates both GIP and GLP-1 receptors.
This dual mechanism is one of the fundamental differences between tirzepatide and semaglutide.
If you want to understand how the two active ingredients compare—including what head-to-head clinical research has found about weight loss—see our complete guide to Semaglutide vs. Tirzepatide: What's the Difference?
Which One Is a Weight Loss Medication?
This question requires more precision than it usually gets online.
For FDA-approved chronic weight management in eligible patients:
Wegovy is a weight-management medication.
Zepbound is a weight-management medication.
Ozempic is not FDA-approved specifically for weight loss.
That doesn't mean people taking Ozempic cannot experience weight loss.
It means weight management isn't an FDA-approved indication for Ozempic.
This distinction is one reason it's worth learning both the active ingredient and the brand name rather than assuming every medication associated with GLP-1 weight loss is the same.
Why the Brand Name Isn't the Whole Story
When you're researching these medications, it's easy to become focused on one question:
"Which medication causes the most weight loss?"
But once treatment begins, a different set of questions becomes much more personal.
How is your weight changing?
How is your appetite changing?
Are you noticing changes in food noise?
What symptoms are you experiencing?
How are your body measurements changing?
Which habits are becoming easier?
What does your eating pattern look like now compared with two months ago?
Are you becoming more active?
Those are questions a medication comparison can't answer.
If a GLP-1-based medication is part of your clinician-guided weight-loss journey, the Semaglutide Weight Loss Tracker helps you document 26 weeks of medication, weight, symptoms, food noise, meals, workouts, habits, body measurements, goals, and reflection. Get your copy and start tracking your experience beyond the number on the scale.
What Side Effects Do Ozempic, Wegovy, and Zepbound Have?
These medications can cause side effects, and gastrointestinal symptoms are among those commonly reported.
Depending on the medication, common side effects can include:
nausea
diarrhea
vomiting
constipation
abdominal pain or discomfort
other gastrointestinal symptoms
The medications also have warnings and potentially serious risks that go beyond common digestive symptoms.
The exact risks, contraindications, and side effects aren't identical for every medication, which is another reason not to treat Ozempic, Wegovy, and Zepbound as interchangeable.
Your healthcare professional and the current prescribing information for your specific medication are the appropriate sources for medical guidance.
Why Track Side Effects?
A symptom tracker isn't a substitute for contacting your healthcare professional when something feels wrong.
What it can do is give you a better record.
Imagine you're several months into treatment and your clinician asks:
"When did the nausea start?"
"How frequently has it happened?"
"Did you notice it around the time your treatment changed?"
Without notes, you may be trying to reconstruct several weeks from memory.
Recording symptoms as they happen gives you information you can bring to that conversation.
You might track experiences such as nausea, fatigue, bloating, constipation, headaches, dizziness, or other symptoms.
The purpose isn't to diagnose yourself.
It's to remember more accurately.
And if a symptom is severe, persistent, unusual, or concerning, contact your healthcare professional rather than simply recording it and waiting.
What Else Is Worth Tracking During a GLP-1 Weight Loss Journey?
Medication is only one part of a weight-loss journey.
If you're going to keep a record, consider looking beyond the prescription itself.
Weight Trends
One weigh-in gives you a number.
Several months of weekly weigh-ins give you a trend.
Those are very different things.
Day-to-day and week-to-week fluctuations can happen for many reasons. Looking at your progress across a longer period can give you a more complete perspective than reacting to one weigh-in.
Body Measurements
Weight isn't the only way your body changes.
Periodic measurements can give you another way to observe progress over time.
This can be particularly encouraging during periods when the scale doesn't appear to be changing very much.
Food Noise
Some people use the informal phrase food noise to describe frequent thoughts, urges, or mental preoccupation surrounding food.
It's not a formal medical measurement, but your subjective experience can still be worth recording.
Tracking how strong those thoughts feel from week to week can help you notice changes in your own experience.
Meals
A food journal can help you become more aware of your eating patterns without requiring you to divide everything into "good" and "bad" foods.
What meals left you satisfied?
Which routines were easiest to maintain?
Did certain patterns make meal planning easier?
What would you like to repeat next week?
The goal is awareness, not perfection.
Movement
Walks, workouts, steps, distance, strength training, repetitions, or other activities can all become part of your record.
This gives you another way to see progress even when the scale isn't changing exactly as you'd hoped.
Habits
Medication can be one component of a much larger health journey.
The routines you're building alongside treatment may deserve just as much attention.
Instead of asking only:
"How much did I lose?"
you can also ask:
"What am I becoming more consistent at?"
Non-Scale Victories
Sometimes progress shows up somewhere other than your scale.
Your clothes may fit differently.
Walking may feel easier.
Your measurements may change.
You may feel stronger.
Perhaps you've followed through on a habit for four consecutive weeks.
Those victories deserve to be recorded too.
Don't Let Someone Else's GLP-1 Journey Become Your Benchmark
Search Ozempic, Wegovy, or Zepbound online and you'll quickly encounter dramatic stories.
Someone lost a certain number of pounds in a month.
Someone else posts an incredible before-and-after photo.
Another person says their appetite changed immediately.
Someone says theirs didn't.
It can become very easy to ask:
"Why isn't my journey happening like theirs?"
But their experience isn't your benchmark.
Clinical-trial averages aren't your personal benchmark either.
Your own starting point is.
That's one of the strongest reasons to keep a weight loss journal throughout the process.
Instead of comparing yourself with a stranger online, you can compare:
Week 12 with Week 1.
Month 5 with Month 1.
Your habits now with your habits then.
Your measurements now with your starting measurements.
Your food noise now with what you recorded at the beginning.
Your consistency.
Your routines.
Your progress.
Build a Record of the Journey, Not Just the Medication
Whether someone is prescribed Wegovy, Zepbound, Ozempic for an approved indication, or another GLP-1-based treatment, the prescription isn't the entirety of their experience.
There's everything happening around it.
Meals.
Movement.
Habits.
Challenges.
Side effects.
Milestones.
Changes in appetite.
Changes in measurements.
Good weeks.
Frustrating weeks.
Things that worked.
Things that didn't.
Those experiences can teach you something—but only if you remember them.
The Semaglutide Weight Loss Tracker turns six months of your GLP-1 journey into a record you can actually look back on. Track your medication and how it was taken, symptoms, weekly weight, food noise, meals, workouts, habits, monthly measurements, goals, rewards, and reflections—all in one guided journal. Get your copy and capture the progress the scale alone can't show you.
Ozempic vs. Wegovy vs. Zepbound: The Bottom Line
Here's the simplest way to remember the differences:
Ozempic contains semaglutide.
Wegovy contains semaglutide.
Zepbound contains tirzepatide.
Semaglutide is a GLP-1 receptor agonist.
Tirzepatide is a dual GIP/GLP-1 receptor agonist.
Wegovy and Zepbound have FDA-approved indications for chronic weight management in eligible patients.
Ozempic does not have an FDA-approved weight-loss indication; it is approved for specific uses involving adults with type 2 diabetes.
While knowing the differences between these medications matters, knowing which medication is appropriate for you requires a conversation with a qualified healthcare professional.
Once you're on your own journey, though, there's another comparison worth making:
Not Ozempic vs. Wegovy.
Not Wegovy vs. Zepbound.
Not your progress vs. somebody else's.
You today vs. where you started.
That's the progress worth tracking.
Medical disclaimer: This article is for general educational and informational purposes only and does not provide medical advice, diagnosis, dosing instructions, or treatment recommendations. Ozempic, Wegovy, Zepbound, semaglutide, and tirzepatide are prescription medications with contraindications, warnings, potential side effects, and drug interactions. FDA-approved indications and prescribing information can change. Talk with a qualified healthcare professional about whether a medication is appropriate for you and how it should be used.
